key: cord-0989236-v0v4dkkz authors: Pfaff, Emily R; Girvin, Andrew T; Gabriel, Davera L; Kostka, Kristin; Morris, Michele; Palchuk, Matvey; Lehmann, Harold P; Amor, Benjamin; Bissell, Mark; Bradwell, Katie R; Gold, Sigfried; Hong, Stephanie S; Loomba, Johanna; Manna, Amin; McMurry, Julie; Niehaus, Emily; Quresh, Nabeel; Walden, Anita; Zhang, Xiaohan Tanner; Zhu, Richard L; Moffitt, Richard A; Haendel, Melissa A; Chute, Christopher G title: Synergies between Centralized and Federated Approaches to Data Quality: A Report from the National COVID Cohort Collaborative date: 2021-09-30 journal: J Am Med Inform Assoc DOI: 10.1093/jamia/ocab217 sha: 3d7b73e9a50d9ed7be3f3c9f84792c3ae4169f6c doc_id: 989236 cord_uid: v0v4dkkz BACKGROUND: In response to COVID-19, the informatics community united to aggregate as much clinical data as possible to characterize this new disease and reduce its impact through collaborative analytics. The National COVID Cohort Collaborative (N3C) is now the largest publicly available HIPAA limited dataset in US history with over 6.4 million patients and is a testament to a partnership of over 100 organizations. METHODS: We developed a pipeline for ingesting, harmonizing, and centralizing data from 56 contributing data partners using four federated Common Data Models. N3C Data quality (DQ) review involves both automated and manual procedures. In the process, several DQ heuristics were discovered in our centralized context, both within the pipeline and during downstream project-based analysis. Feedback to the sites led to many local and centralized DQ improvements. RESULTS: Beyond well-recognized DQ findings, we discovered 15 heuristics relating to source CDM conformance, demographics, COVID tests, conditions, encounters, measurements, observations, coding completeness and fitness for use. Of 56 sites, 37 sites (66%) demonstrated issues through these heuristics. These 37 sites demonstrated improvement after receiving feedback. DISCUSSION: We encountered site-to-site differences in DQ which would have been challenging to discover using federated checks alone. We have demonstrated that centralized DQ benchmarking reveals unique opportunities for data quality improvement that will support improved research analytics locally and in aggregate. CONCLUSION: By combining rapid, continual assessment of DQ with a large volume of multi-site data, it is possible to support more nuanced scientific questions with the scale and rigor that they require. Clinical data repositories from EHR sources have evolved over the decades. Ad-hoc database designs from the early period of EHR adoption had limited generalization across sites. The earliest federated models [5] in the 1990s ultimately gave rise to Sentinel [6] and to Common Data Models (CDMs) such as PCORnet [7] , the Accrual to Clinical Trials (ACT) network [8] , TriNetX [9] [10] [11] , and Observational Medical Outcomes Partnership (OMOP), which later became Observational Health Data Sciences and Informatics (OHDSI) [12] [13] [14] . In a federated data network, each participating site's data stay behind its institutional firewall, but are structured according to a CDM. This enables queries and results to be shared across sites rather than raw data. The CDMs have been key to using EHR data for research; however, secondary analytic uses -particularly involving multiple contributing sites --require resource-intensive quality control to achieve the required uniformity and specificity to support open-ended research [15] [16] [17] [18] . Despite their importance, data quality (DQ) checks are inconsistently applied and implementation methodologies are largely not evaluated [17, 19] . Further, evaluations of DQ often fail to accurately determine the data's "fitness for use," which evaluates both its intrinsic and intentional aspects. [20] [21] [22] DQ evaluations must take into account the initial purpose of the data in their source systems, as well as the intended use of these data once harmonization processes have transformed them for use in secondary research. [19, 23, 24] Each of the aforementioned federated networks has methods to promote local DQ and adherence to data model conventions; these methods vary in maturity. As examples, OHDSI offers its Data Quality Dashboard [25] tool for sites to run against their local CDM in order to evaluate adherence to OMOP CDM convention and diagnose common issues; PCORnet requires a quarterly data "curation" and quality check that uses pre-packaged SAS scripts; [26] ACT has a "smoke test" to ensure federated network query response and has a Data Quality Dashboard of its own under development; and TriNetX employs a growing library of DQ metrics and visualizations with site benchmarking as the basis for evaluating the results. Because the data are federated, DQ evaluation and remediation are performed locally at the site by site personnel. These local checks ensure that data conform to the specifications of the chosen CDM, and may also check for data anomalies such as statistical outliers, invalid dates, biological implausibility, abundant missing data, and other common clinical data issues. Such approaches support alignment of data; however, with the data remaining behind the institutional firewalls, it can be difficult to assess conformance or determine overall variability across sites, especially if the CDM does not have the capability of executing ad hoc DQ-related queries across the data network. In contrast to the federated approach, N3C pools data from each partner site in accordance with its signed Data Transfer Agreement, [4] and harmonizes all submitted data to the OMOP CDM. By the time data are submitted to N3C, sites have already applied a layer of local DQ checks, and are submitting data that are "clean" by the local definition. Once data are merged across sites, additional opportunities for improvement may become apparent due to the ability to efficiently compare and benchmark among similar sites. [27] N3C centralized DQ methods complement and augment the foundation accomplished by sites in the context of the federated networks. Data quality emerged in the 2010s as an explicit subject of attention and research in informatics [22, 28, 29] . Notably, PCORI funded an effort to define DQ, resulting in the "Harmonization" framework of Kahn and colleagues [20] . The dimensions of DQ defined there (internal verification, external validation, conformance, completeness, and plausibility) are the basis of the PCORnet [26] and OHDSI [30] conception and framework for DQ checking. N3C continued to build on this foundation for our centralized DQ approach. To describe N3C's approach to DQ curation, and explore the value that a centralized data architecture and approach to DQ adds to what sites can accomplish locally, either alone or in the context of a federated data research network. N3C has engaged in a precedent-setting endeavor to centrally harmonize the four major CDMs (OMOP, PCORnet, ACT, TriNetX) into OMOP. This enables N3C's EHR dataset to span 56 institutions at the time of this writing while putting minimal burden on sites themselves. The EHR data spans multiple data domains, including patient demographics, encounter details, diagnoses, procedures, medications, lab tests, and clinical observations; a detailed list of supported fields can be found in the OMOP 5.3.1 common data model specification. [28] The pipeline evolved over three implementation environments, and is presently running in Palantir Foundry. [ Figure 1 ] After transformation to OMOP, each site's inaugural N3C submission is loaded into the N3C Data Quality Portal (DQP), which performs a series of automated DQ checks prior to manual evaluation by the Data Ingestion & Harmonization (DI&H) team (see Acknowledgements for members). The DQP is built on queries similar to OHDSI's Data Quality Dashboard, and provides a series of targeted visualizations that allow the team to assess each site's DQ in areas of importance for COVID research (see Table 1 ). The DQP supports site data review both in the context of the site's source CDM and in comparison to the other three CDMs. N3C purposely uses a light touch during these DQ checks, placing a high value on including as much submitted data as possible, with the understanding that each site's data likely contains local idiosyncrasies and inconsistencies that are acceptable so long as they are known. Such issues (e.g., a site is able to provide only outpatient data, only supports a subset of vital signs, or is frequently missing units of measure) can be reported in N3C's release notes, but would not prevent a site from "passing" on to inclusion in that week's release. Issues that can prevent sites from passing ("Must Pass"), and thus make up our minimum data standards, are detailed in Table 1 . Issues that do not prevent passage but are still of concern are labeled "Heads Up." Heads Up: The site supports only a small number (e.g., 5-10) of unique measurement or observation types Must Pass: No more than 20% of records in any domain are coded with nonstandard OMOP concept IDs without further explanation (OMOP sites only); no more than 20% of records in any domain are coded with "0 -No Matching Concept" without further explanation (affects OMOP sites only); the PERSON_ID attached to all records in domain tables must exist in the PERSON table; primary keys are valid (i.e., no duplicate rows in any table); if applied by the site, date shifting is consistent within each patient across all domains Use of the data by researchers often reveals additional DQ issues for one or more sites (e.g., sparsely populated body mass index data, in the context of a study of obesity and COVID). In these cases, we report the findings to sites so that they can take action in their local data if they wish to have their site's data included in the study. As previously described, [1] N3C's signature "white glove," or one-on-one DQ support, provides feedback and individualized source model-specific help to sites. Members of N3C's Phenotype and Data Acquisition team (P&DA; see Acknowledgements for members) serve as liaisons between sites and the DI&H team. The P&DA team is composed of subject matter experts in each of N3C's four supported data models. Each site is assigned an expert in their source model as their P&DA point of contact. After a site's initial payload is evaluated using the DQP, the site's P&DA contact compiles a list of data issues in the "must pass" and "heads up" categories and emails that list to the site. Corrections are generally iterative in nature, and correction cycles will continue until the site passes all "must pass" checks. Some corrections are simple, while others require individual troubleshooting meetings with the P&DA team, attendance at P&DA office hours, or sharing code snippets. More recently, we have started an initiative to provide some of the benchmarking data generated by the DQP directly to sites, in visual format. Our centralized architecture gives us the unique ability to provide this type of benchmarking data, and may reveal opportunities for DQ improvement of which sites were previously unaware. One of the visualizations we sent, a heatmap illustrating "coverage" of different vital signs for COVID inpatients across a variety of (anonymized) sites, is shown in Figure 2 . These visualizations allow sites to compare their data quality to that of other sites that are using the same CDM. Hierarchical clustering was used to bring together sites with similar profiles of vital reporting. [ Figure 2 ] To assess the impact of N3C DQ feedback on sites' local DQ, we reviewed all submitted DQ issues filed on site data in the N3C Data Enclave, and performed a qualitative analysis to extract DQ heuristics, as well as the number of sites to which each heuristic applied. Only "released" sites (i.e., sites whose data is available for research in the Enclave) were included in the analysis; a denominator of 56 sites. Issue instances were counted if they were in the " Must 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 Pass" category. Sites that are still working through data issues (and are thus not yet released) are not included in the denominator, and "Heads Up"-type issues or simple formatting errors (e.g., incorrect delimiters, missing headers, etc.) were not included in the count of issues. Table 2 provides an accounting of the DQ issues found and improvements made by N3Cparticipating sites based on our feedback. These improvements map to the checks we perform against each site's first payload, detailed earlier in Table 1 . Example of Heuristic #1: Not using (or improperly using) source CDM's controlled vocabulary in one or more fields There are numerous examples of fields that require controlled vocabularies among the four source CDMs. Nearly a quarter of all N3C sites have violated the use of these vocabularies on one or more occasions within their source CDM. Examples of this issue include non-use or improper use of the ACT race and ethnicity vocabulary (e.g., using local codes rather than the controlled vocabulary's value sets), incorrect DX and DX_TYPE agreement (e.g., labelling an ICD-10-CM diagnosis code as type "Other") in PCORnet, or using standard concepts in an inappropriate domain (e.g., filing conditions wrongly in the OBSERVATION table) in OMOP. These types of errors often create the illusion of missing data. Having centralized access to sites' source data gives the N3C team the ability to diagnose the issue in detail and offer sites ways to remedy the problem. Eleven sites submitted non-standard, null, or otherwise unusable COVID test result values in their initial submissions. Quality issues included: • Non-harmonizable COVID test results (e.g., submitting a free-text result rather than the source CDM's controlled vocabulary equivalent) • Null COVID test results in excess of a reasonable number of pending results • COVID test results that used the source CDM's controlled vocabulary, but mapped to an unusual concept (e.g., one site mapped results to OMOP concept ID 45877980, "Not," presumably for a negative test) Even where it is not a source CDM requirement to map every qualitative test result to the CDM's controlled vocabulary, for N3C's use case, harmonized COVID tests are essential. We worked with sites to prioritize these mappings, even as new COVID test codes continued to emerge over the course of the pandemic. Figure 3 shows the improvements made by these eleven sites over time. [ Figure 3 ] Each source CDM has its version of an encounter or visit table, as well as a controlled vocabulary to assign a "type" to visits, such as inpatient, outpatient, or emergency. Different models' vocabularies have different levels of specificity for visit types; the N3C DQ process accounts for this by aggregating multiple valid visit type codes to a higher level category (e.g., "Inpatient Hospital" and "Inpatient Visit" in the OMOP vocabulary can roll up to an overall category of Inpatient for the purposes of quality analysis). Even when these roll-ups are taken into account, however, seven N3C sites had implausible distributions of visit types, where implausibility was defined by the overall distribution across sites. Such implausibility is illustrated here for five of the seven sites that specifically had an implausible proportion of inpatient visits. One of the five sites started with inpatient visits significantly above the mean (Figure 4a) , while the other four had significantly fewer (Figure 4b) . As shown in Figure 4 , after feedback from N3C, all five sites improved the quality of their visit type mappings to bring their inpatient visit proportion closer to the mean. Of note, the proportions at times worsened with subsequent payloads, pointing out the need for recurring vigilance: Fixing a problem once does not mean it stays fixed. [ Figure 4 ] A number of N3C data quality findings have come from analysts using the data, spotting inconsistencies, and submitting issue tickets. One such example involves data on mortality, the most commonly investigated endpoint in N3C. Generally, sites document patient deaths in their source CDM with pairs of patient IDs and death dates. However, because not all CDMs require a death date to be present to note a patient as deceased, numerous sites provide patients IDs, but no dates. In one instance, a site's Death data table included all of their patient IDs (for both living and deceased patients); in their definition, a null date denoted a living patient, and a populated date denoted a death. Taken individually, each of these structures makes sense. However, aggregate analyses that either ignore missing dates or require dates to be present would come to drastically different conclusions, either over-or underestimating mortality. In these cases, we worked individually with sites to standardize where possible, and in other cases provided user education and analytical workarounds. Other researcher-identified site-level issues include those tied to a particular type of measurement, such as a misrepresented unit of measure for a specific type of value (discovered when comparing height/weight calculated BMI to reported BMI) or mismapped measurements (discovered when reviewing mean SpO 2 by site). In each case, the DQ concern was referred for further "upstream" remediation in the pipeline beyond the project that discovered it and the site was informed. We have demonstrated that centralized DQ assessment reveals unique opportunities for iterative quality improvement for submitting sites. N3C's DQ checks take into account various dimensions introduced in prior DQ work, such as conformance to source data models, density and completeness (e.g., of COVID test results), and plausibility (e.g., of percentage of inpatient visits). [20, 29] . By participating in a consortium like N3C, sites receive routine feedback on their overall quality with tactical information on ways to address local issues. Moreover, N3C's dedicated team of analysts with protected time to concentrate on DQ, deep subject matter expertise, and access to powerful visualization tools enable efficient support for participating sites in making rapid improvements in high-priority areas. This process can be transformative; by combining efficient, continual assessment of DQ with a large volume of multi-site data, it is possible to support more nuanced scientific questions with the scale and rigor that they require. When examining data across N3C partner sites, the centralized approach revealed significant site-to-site DQ differences that would have been challenging to discover in isolation. Many of these "data issues" are indeed errors, but others arise from differences in interpretation or adoption of CDM components. Sites' use of the encounter data domain is an example, where the definition of "one visit" can vary widely depending on the site's EHR, organizational structure, or billing practices (see Figure 5 ). The site's definitions of various visit types are generally not erroneous, and likely comply with the rules of their source CDM. Problems surface, however, when data are combined across sites for multi-site projects, leading to a need for data users to (1) understand that the issue exists, and (2) develop consistent analytic workarounds and harmonization strategies. Benchmarking, or the ability to compare sites with their peers, is an efficient way to catch such issues. [ Figure 5 ] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 Assessing the quantity and variety of data available per patient is another use case for benchmarking. Because instantiation and maintenance of CDMs is resource-intensive, it is common for sites to take a minimalistic approach to CDM data curation, particularly in the early days of implementing a new CDM. This may entail purposely choosing to support only a small number of lab tests, vitals, or other observations (e.g., the top fifty most common labs; only blood pressure, weight, and height out of all possible vital measurements, etc.). However, this sparsity can have a big impact on what research questions are possible to answer using the data. Because N3C aims to be a multi-purpose resource for COVID research, we use benchmarking to spot sites supporting fewer facts per patient (or a limited variety of clinical concepts), and encourage them to gradually add on as they can. Benchmarking data can also serve as a clear and persuasive DQ communication tool. As shown in Figure 2 , our ability to compare sites' coverage of lab and vital concepts across sites gives sites a "report card" to see which concepts have more or less coverage at their peer sites. This information can help sites prioritize bringing in new types of data, or may spur an investigation of a data issue of which the site was unaware. It should be noted that federated networks (particularly PCORnet and TriNetX) are also capable of site-to-site benchmarking, but at an aggregated rather than detailed level. To use Figure 5 as an example, aggregate checks could produce the inpatient visit counts reported on the left side, but would not enable the rowlevel deep dive shown on the right. Though row-level checks enable more detailed benchmarking, both aggregate and row-level comparisons are highly valuable. The N3C repository not only pools data, but also brings together multi-disciplinary teams of clinicians, researchers, and statisticians from across the network of organizations with N3C Data Use Agreements. N3C Enclave researchers are invited to join any of more than 25 Clinical Domain Teams, where they can share domain-specific knowledge with a diverse set of peers. Researchers who join a Domain Team have access to a shared workspace where they can create sets of derived variables specific to their research question and conduct related analyses. As detailed dataset reviews are an essential step in this process, these teams may reveal resolvable data issues such as hard-to-harmonize variations among contributing CDMs or incorrect mappings at the individual record level. Sometimes these quality errors, inconsistencies, or omissions are remedied within the Enclave by N3C, such as unit of measure harmonization, whereas for other issues these discoveries are referred back to the contributing site for remediation. The ability for research teams to review row-level data in the N3C Enclave also helps end users write more accurate analytic code by avoiding blind assumptions related to how representation of clinical facts varies by site or CDM. For example [30] , when creating a flag to indicate the cooccurrence of a positive COVID test and a diagnosis code representing a comorbidity, date logic is applied in the code. Review of row-level data, which can be filtered to one or more sites whose variable distribution does not match other sites, may reveal that some measurement dates are representative of test result date instead of test order date--either of which may be acceptable in the source CDM. Though the data are not "wrong" in this case and do not need to be corrected by the contributing site, this ambiguity is a DQ issue nonetheless and requires resolution by data users during analysis. In general, identification of DQ issues that are highly dependent on the context of use [31, 32] are, by design, left for analysts pursuing specific questions to discover. In such cases, our centralized DQ team serves as a liaison to the sites, and passes feedback from analysts to sites for local discussion and remediation, if deemed necessary and high-value by the site. Issues of this type are extremely challenging or impractical to identify without access to the row-level data, in addition to the ability to compare across sites. While centralization alone is not a recipe for improved DQ, it does present opportunities to implement generalized solutions at scale. N3C adopted two post-processing DQ processes that illustrate this: (1) interrogating information "loss" in standardized terminology mappings and (2) performing post-hoc evaluation of harmonized clinical information to ensure analytical utility. These solutions are more practical to achieve in a centralized environment where economy of scale provides the ability to easily see strings or terms that could be supported in value sets, or logic that could be modified to bring clinical information to the right analytical domain. Moreover, a centralized data ingestion pipeline allows for bidirectional improvement as the target model (OMOP, in this case) can evolve to include conventions that capture the heterogeneity of source system data. Finally, centralized review simply puts additional trained eyes on a site's data. The advantages to this are demonstrated by the fact that N3C's centralized review process found errors and room for improvement even in data that had passed either local review or one of the federated networks' required checks. Indeed, this combination of local checks, by personnel who intimately understand their site's data, and centralized checking, which can take advantage of economies of scale, may represent an ideal model for DQ assessment. N3C is devoted to a single disease, so some of our particular DQ checks derive from that focus. Though many of the issues identified here (e.g., encounter definitions, unit harmonization, plausibility) are not limited to COVID-related data, the emphasis of our suite of DQ checks is on variables required for COVID research. As an example, we ensure careful harmonization of qualitative COVID lab test results, but do not perform checks at the same level of detail on non-COVID labs. Still, many of our checks listed in Table 1 can apply to clinical data more generically. Centralization does mean that data are further from the EHR source, and we rely on local staff to be final arbiters of their own DQ. Additionally, as sites may have already executed one of the federated networks' DQ checking protocols prior to submitting to N3C, the data that N3C receives may have already undergone a prior round DQ improvements. Yet, based on our results, we feel that the insights that sites receive from the composite experience of the entire Enclave adds value even to previously improved data. Despite the efficiency that N3C's centralized Enclave enables for the assessment of DQ issues, much of the heavy lift of definitive DQ remediation lies with the submitting sites. We acknowledge that consortial data resources such as N3C are only possible because of the efforts of local teams, and believe that centralized DQ supports collaboration and knowledge exchange that also helps improve local data quality. In informatics research, there is generally limited funding available to specifically support local DQ, which makes N3C sites' engagement with our DQ process all the more impressive. This may be an indicator of demand for more centralized DQ in the future, given ongoing funding to do so. The ability to take some of the DQ workload off of local sites may incentivize site participation in future centralized repositories. Federated data repositories, where the data remains at the generating site, offer the advantages of local curation by personnel deeply familiar with the data. Central repositories enable efficient data quality benchmarking at scale, and the generation of derivative, harmonized variables and units of measure for comparable and consistent analytics. Together, these advantages can synergize to a best of both worlds approach for DQ improvement and enhancement in clinical data repositories. Cooperation and communication between these complementary environments, as illustrated by the common data model communities and N3C, promise mutual advantage and maximal data quality. • 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 Participating sites regularly submit data in their native CDM format to an ingest server. A parsing step validates whether the data is formatted properly and checks the contents of the payload against its package description, or "manifest." The pipeline then transforms the submitted data to the OMOP model; data provenance is automatically maintained such that transformed data can be traced back to source at any time. The transformed data are then reviewed for DQ by a team of subject matter experts using a suite of data characterization and visualization tools. Every week, the latest data from all sites passing DQ checks are published as a versioned "release" for use by investigators. This heatmap is representative of those that we sent to sites to provide them with benchmarked lab and vital coverage information. The rows represent concept sets for vital signs, and the columns are individual sites. The cell colors reflect the zscore of the percentage of COVID inpatients at each site that have at least one lab or vital of that type recorded during their hospitalization The bluer the color, the higher the percentage of COVID inpatients that have that vital sign at that site-redder shades mean a lower percentage of patients with that vital. Rows and columns are hierarchically clustered, bringing similar sites closer together, and similar vitals closer together. This visualization enables sites to compare their data coverage with other sites using the same data model. (Site numbers are anonymized, and have been changed from the site numbers used inside the N3C Enclave.) . In a, one site's initial N3C submission had a proportion of visits of type inpatient far above that of similar sites; in b, four sites' initial submissions had no (or nearly no) inpatient visits. Our feedback encouraged the sites to reexamine and remap their source-to-CDM visit type mappings. In these cases, proportions improved. The shaded area reflects the mean and standard deviation of all sites. Figure 5 . Comparing sites within centralized data. One of the most stark differences we have observed among different sites is the different ways that a "visit" (or encounter) can be defined. Indeed, inpatient visits at several N3C sites are made up of a number (at times hundreds) of "microvisits"--consults with different specialists, MRIs, infusions, et cetera. Because sites define inpatient visits so differently, they are difficult to harmonize. Centralized data makes it easier to compare how sites define visits, and develop derivative variables to enable harmonization. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 Chunlei Wu • Key liaisons and regulatory staff at data partner sites • Individuals at the sites who are responsible for creating the datasets and submitting data to N3C Analytics Team (Individuals who build the Enclave infrastructure, help create codesets, variables, and help Domain Teams and project teams with their datasets The National COVID Cohort Collaborative (N3C): Rationale, design, infrastructure, and deployment The national COVID Cohort Collaborative: Clinical characterization and early severity prediction N3C Cohort Exploration COVID-19 Data Warehouse Data Transfer Agreement The Role of Research in Integrated Health Care Systems: The HMO Research Network Developing the Sentinel System--a national resource for evidence development Launching PCORnet, a national patient-centered clinical research network Using EHR data extraction to streamline the clinical trial process Use of electronic health data in clinical development Using real world data to assess cardiovascular outcomes of two antidiabetic treatment classes model enabling active drug safety surveillance using disparate healthcare databases Advancing the science for active surveillance: rationale and design for the Observational Medical Outcomes Partnership Observational Health Data Sciences and Informatics (OHDSI): Opportunities for Observational Researchers Innovative Solutions for State Medicaid Programs to Leverage Their Data, Build Their Analytic Capacity, and Create Evidence-Based Policy Improving data quality in observational research studies: Report of the Cure Glomerulonephropathy (CureGN) network Assessing the practice of data quality evaluation in a national clinical data research network through a systematic scoping review in the era of real-world data A pragmatic framework for single-site and multisite data quality assessment in electronic health record-based clinical research Design and Refinement of a Data Quality Assessment Workflow for a Large Pediatric Research Network A Harmonized Data Quality Assessment Terminology and Framework for the Secondary Use of Electronic Health Record Data A comprehensive framework for data quality assessment in CER Methods and dimensions of electronic health record data quality assessment: enabling reuse for clinical research Improving a Secondary Use Health Data Warehouse: Proposing a Multi-Level Data Quality Framework How the provenance of electronic health record data matters for research: a case example using system mapping Evaluating Foundational Data Quality in the National Patient-Centered Clinical Research Network (PCORnet®) Data Quality Assessment and Multi-Organizational Reporting: Tools to Enhance Network Knowledge Defining and measuring completeness of electronic health records for secondary use Feasibility of capturing real-world data from health information technology systems at multiple centers to assess cardiac ablation device outcomes: A fit-for-purpose informatics analysis report Data Quality in Clinical Research We gratefully acknowledge contributions from the following N3C core teams (leads indicated with an asterisk)• Principal Investigators: Melissa A. Haendel*, Christopher G. Chute*, Kenneth R. Gersing, Anita Walden